Human Cerebrospinal Fluid Monoclonal LGI1 Autoantibodies Increase Neuronal Excitability
Open Access
- 3 January 2020
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 87 (3) , 405-418
Abstract
Objective: Leucine‐rich glioma‐inactivated 1 (LGI1) encephalitis is the second most common antibody‐mediated encephalopathy, but insight into the intrathecal B‐cell autoimmune response, including clonal relationships, isotype distribution, frequency, and pathogenic effects of single LGI1 antibodies, has remained limited.Methods: We cloned, expressed, and tested antibodies from 90 antibody‐secreting cells (ASCs) and B cells from the cerebrospinal fluid (CSF) of several patients with LGI1 encephalitis.Results: Eighty‐four percent of the ASCs and 21% of the memory B cells encoded LGI1‐reactive antibodies, whereas reactivities to other brain epitopes were rare. All LGI1 antibodies were of IgG1, IgG2, or IgG4 isotype and had undergone affinity maturation. Seven of the overall 26 LGI1 antibodies efficiently blocked the interaction of LGI1 with its receptor ADAM22 in vitro, and their mean LGI1 signal on mouse brain sections was weak compared to the remaining, non–ADAM22‐competing antibodies. Nevertheless, both types of LGI1 antibodies increased the intrinsic cellular excitability and glutamatergic synaptic transmission of hippocampal CA3 neurons in slice cultures.Interpretation: Our data show that the patients’ intrathecal B‐cell autoimmune response is dominated by LGI1 antibodies and that LGI1 antibodies alone are sufficient to promote neuronal excitability, a basis of seizure generation. Fundamental differences in target specificity and antibody hypermutations compared to the CSF autoantibody repertoire in N‐methyl‐D‐aspartate receptor encephalitis underline the clinical concept that autoimmune encephalitides are very distinct entities. Ann Neurol 2020;87:405–418Keywords
Funding Information
- Federal Ministry of Education and Research (SMARTAGE 01GQ1420A)
- German Research Association (Exc 257, PR 1274/2‐1, PR 1274/3‐1, SFB 1315, SFB 958, SPP 1665, FOR 3004)
- Helmholtz Association
- JSPS (17H03678, 19H03331, 19K22548)
This publication has 48 references indexed in Scilit:
- Autoantibodies to Epilepsy-Related LGI1 in Limbic Encephalitis Neutralize LGI1-ADAM22 Interaction and Reduce Synaptic AMPA ReceptorsThe Journal of Neuroscience, 2013
- Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case seriesThe Lancet Neurology, 2010
- Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotoniaBrain, 2010
- Electroclinical characterization of epileptic seizures in leucine-rich, glioma-inactivated 1-deficient miceBrain, 2010
- Cellular and Synaptic Mechanisms of Anti-NMDA Receptor EncephalitisThe Journal of Neuroscience, 2010
- Disruption of LGI1–linked synaptic complex causes abnormal synaptic transmission and epilepsyProceedings of the National Academy of Sciences, 2010
- Lgi1 null mutant mice exhibit myoclonic seizures and CA1 neuronal hyperexcitabilityHuman Molecular Genetics, 2010
- AMPA receptor antibodies in limbic encephalitis alter synaptic receptor locationAnnals of Neurology, 2009
- Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloningJournal of Immunological Methods, 2008
- Dendritic D‐type potassium currents inhibit the spike afterdepolarization in rat hippocampal CA1 pyramidal neuronsThe Journal of Physiology, 2007